Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioAuxilium Research is a private Canadian life science tools company focused on TR-FRET-based assay kits and custom assay development for drug discovery and biomedical research. The company designs, develops, and manufactures ready-to-use THUNDER TR-FRET assay kits, toolbox reagents, control lysates, and related buffers for biomarker quantification, cell signaling analysis, and cAMP detection. It also offers contract services including custom TR-FRET assay development, ELISA-to-homogeneous assay conversion, biomolecule labeling, and biochemical and cell-based assay optimization. BioAuxilium appears to operate as a research tools and services business rather than a therapeutics developer, so it does not have a traditional clinical drug pipeline. Its value proposition centers on affordable, validated homogeneous assays that simplify workflows and support preclinical and translational research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioAuxilium Research.